Navigation Links
Sunridge Middle East Distributor to Begin Clinical Trials Necessary for Reimbursement
Date:12/8/2010

FOUNTAIN HILLS, Ariz., Dec. 8, 2010 /PRNewswire-FirstCall/ -- Sunridge International (OTC Bulletin Board: SNDZ), announced today that Ameco Medical is preparing to start the short term clinical trials needed for reimbursement approval.  

Ameco Medical Equipment L.L.C., Sunridge's exclusive distributor for several Middle Eastern countries, has invited Dr. Leo D. Bores, Sunridge's medical consultant, to attend the start of their clinical trials.  Dr. Bores would be traveling to multiple countries in the Middle East to work with key opinion leaders at some of the largest hospitals and clinics in the region.  The purpose of the study will be to achieve reimbursement approval for the PNT procedure throughout the area.  

Sunridge International's CEO, G. Richard Smith states, "We strive to have a close working relationship with our distributors so that we can assist them when needed in order to obtain success.  Once reimbursement is established, the tens of thousands of glaucoma sufferers can avail themselves of this non-invasive treatment."

Glaucoma is the second leading cause of blindness, affecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe, effective, non-invasive and cost effective alternative for treatment for glaucoma and ocular hypertension. The 2-minute treatment has been developed, patented, and distributed by Sunridge International, wholly owned subsidiary, Ophthalmic International www.oi-pnt.com. CONTACT:Jeff Smith, Sunridge InternationalT:  +1-480-837-6165e-mail: info@sunridgeint.comMEDIA:Victor Webb, Marston Webb InternationalT: (212) 684-6601e-mail: marwebint@cs.com
'/>"/>

SOURCE Sunridge International
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Sunridge Schedules Public Conference Call
2. Sunridge Receives Reorder on $4 Million Indian Contract
3. Sunridge Advances its PNT Glaucoma Treatment Throughout China
4. Sunridge to Introduce Their PNT Treatment for Glaucoma to Medical Personnel in India
5. Sunridge Ships First Order to the Middle East
6. Sunridge Schedules European Meetings
7. Sunridge Announces Marketing Roll Out of PNT in the Dominican Republic
8. NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa
9. Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
Breaking Medicine News(10 mins):